B+
Bull case
20%
Probability
Target price
$37.91
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
ORKA
Oruka TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$27.08
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$16.25
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2025-11-17
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
0.0
Score
AI commentary
Neutral-to-cautious tone after the official close: limited near-term catalysts and common small‑cap biotech execution and financing risks are keeping investor conviction muted.
RankAlpha Sentiment AI - 2025-11-17
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
No AI events listed.
View full catalyst timelineRecommendation
N/A
No formal recommendation provided.
As of 2025-11-17 • Updated nightlySource: Internal modelMethodology